IVX Invion Limited
—Mkt Cap: —P/E: —1d ago
Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in South Korea. The company develops IVX-PDT, a …
Industry Peers
Drug Manufacturers - General$1.12TUSDP/E 40.5
$610.38BUSDP/E 28.7
$500.80BUSDP/E 80.1
$370.64BUSDP/E 25.2
$364.40BUSDP/E 24.8
$358.21BUSDP/E 115.2
ROG
Roche Holding AG$340.19BUSDP/E 22.7
$288.24BUSDP/E 24.0
$285.83BUSDP/E 22.0
$260.71BUSDP/E 25.2
$260.59BUSDP/E 26.7
$258.50BUSDP/E 23.9
$234.65BUSDP/E 26.1
$260.87BUSDP/E 25.4
$195.13BUSD
$174.33BUSDP/E 10.1
$173.08BUSDP/E 9.6
$167.80BUSDP/E 38.7
$123.73BUSDP/E 12.8
$98.21BUSDP/E 14.9
Key Statistics
Company
Market Cap—
Enterprise Value3.30M USD
Revenue (TTM)265.86K USD
Gross Profit-758.90K USD
Net Income (TTM)-6.09M USD
Revenue/Share0.0040 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryDrug Manufacturers - General
ISINAU000000IVX4
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.21
EV/Revenue12.42
P/S9.93
P/B0.71
EPS (TTM)-0.06
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin-285.45%
Oper. Margin-567.07%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-106.75%
ROA-92.82%
Growth
Revenue Growth12675.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.64M USD
CapEx (TTM)—
FCF Margin-484.81%
FCF Yield—
Net Debt660.16K USD
Net Debt/EBITDA-0.24
Balance Sheet
Debt/Equity29.09
Current Ratio0.24
Quick Ratio0.21
Book Value/Sh0.05 AUD
Cash/Share0.0050 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateNov 20, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.109.20M
Float61.37M
Insiders42.27%
Institutions0.00%
Technical
SMA 500.0390 AUD
SMA 2000.0568 AUD
Beta0.45
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)63.54K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—